Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories
Description
Dysregulated human peptidases are implicated in a large variety of diseases such as cancer, hypertension, and neurodegeneration. Viral proteases for their part are crucial for the pathogens' maturation and assembly. Several decades of research were
